Real stories. Real impact. A better world.
GOOD NEWS DAILY
AllAnimalsCommunityEconomyEnvironmentHealthHumanityInnovationScienceWeekly Recap

Topic

Medical research progress

New findings from labs, clinical trials and hospitals, with the stage of each study made clear: cells, mice, small trials or approved care.

Updated

Plastic anatomical models of the human heart on a table
Health

USF Lab Is Building Living Heart Valves That Could Grow With Children

About this topic

Most medical progress arrives in small steps. In 2025, the US Food and Drug Administration's drug center approved 46 novel drugs, medicines never before approved or marketed in the United States. Each of them began years earlier as the kind of result reported on this page: a lab finding, an animal study or a small trial.

That is why we state the stage of every study. A treatment that works in cells or mice often fails in people, and an early trial with a few dozen patients shows what is worth testing further, not what doctors should prescribe. When a study was done in animals, we say so near the top of the story, and for human studies we report how many people took part.

Recent stories include an MIT team using AI to design mRNA vaccines that stay stable for a year at room temperature, a UK support program that helped four times as many chronic pain patients quit strong opioids, a simple urine test that could help save hundreds more donor kidneys each year, and a University of South Florida lab building living heart valves that could grow with children.

We link to the university, hospital or journal behind each result and use the researchers' own description of what comes next, such as a larger trial or a regulatory review. These stories report research, not medical advice: talk to a doctor before changing any treatment.

Questions and answers

How many new medicines are approved each year in the United States?
The FDA's drug center approved 46 novel drugs in 2025, meaning medicines never before approved or marketed in the US. (Source: U.S. Food and Drug Administration)
Why do so many stories say a treatment is only in an early trial?
Treatments are tested in stages: phase 1 checks safety in a small group, phase 2 checks whether the treatment seems to work, and phase 3 compares it with the current standard in hundreds to thousands of people. (Source: National Cancer Institute)